Detail Information of Microbiota Influence
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0030 Transporter Info | ||||
| Gene Name | SLCO1B3 | ||||
| Transporter Name | Organic anion transporting polypeptide 1B3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Microbiota Influence of This DT (MBI) | |||||
|---|---|---|---|---|---|
|
Bacteria: Host unspecified microbiota |
|||||
|
Genus: Unknown microbiota |
|||||
|
Host unspecified microbiota |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
||||
|
Microbe Influence 1 |
Up regulating of SLCO1B3 expression in the health condition | [1] | |||
|
Regulating Factor |
|||||
|
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
|
Studied Tissue |
Liver | ||||
|
Detailed Description |
The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B3. | ||||
|
Microbe Influence 2 |
Up regulating of SLCO1B3 expression in the health condition | [1] | |||
|
Regulating Factor |
|||||
|
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
|
Studied Tissue |
Liver | ||||
|
Detailed Description |
The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B3. | ||||
|
Microbe Influence 3 |
Up regulating of SLCO1B3 expression in the health condition | [1] | |||
|
Regulating Factor |
|||||
|
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
|
Studied Tissue |
Liver | ||||
|
Detailed Description |
The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B3. | ||||
|
Microbe Influence 4 |
Up regulating of SLCO1B3 expression in the health condition | [1] | |||
|
Regulating Factor |
|||||
|
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
|
Studied Tissue |
Liver | ||||
|
Detailed Description |
The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B3. | ||||
|
Microbe Influence 5 |
Up regulating of SLCO1B3 expression in the health condition | [1] | |||
|
Regulating Factor |
|||||
|
Regulation Mechanism |
via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) | Transcription Factor Info | |||
|
Studied Tissue |
Liver | ||||
|
Detailed Description |
The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLCO1B3. | ||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022 Sep;237:108238. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.